Authors Li, YX; Ye, TY; Xu, L; Dong, YH; Luo, Y; Wang, C; Han, YF; Chen, K; Qin, MZ; Liu, YJ; Zhao, YF in ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER published article about LEUKEMIA; STRATEGY; SB1518 in [Li, Yingxiu; Ye, Tianyu; Xu, Le; Dong, Yuhong; Luo, Yong; Wang, Chu; Han, Yufei; Chen, Ke; Qin, Mingze; Liu, Yajing; Zhao, Yanfang] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China; [Qin, Mingze] Chinese Peoples Liberat Army Logist Support Forte, Dalian 116021, Peoples R China in 2019, Cited 24. Name: 2-Aminobenzamide. The Name is 2-Aminobenzamide. Through research, I have a further understanding and discovery of 88-68-6
Hybridization strategy is an effective strategy to obtain multi-target inhibitors in drug design. In this study, we assembled the pharmacophores of momelotinib and tandutinib to get a series of 4-piperazinyl-2-aminopyrimidine derivatives. All compounds were tested for the inhibition of JAK2 and FLT3 enzymes, of which, compounds with potent enzyme activities were assayed for antiproliferative activities against three cancer cell lines (HEL, MV4-11, and HL60). The structure-activity relationship studies were conducted through variations in two regions, the A phenyl ring and B phenyl ring. Compound 14j showed the most balanced in vitro inhibitory activity against JAK2 and FLT3 (JAK2 IC50 = 27 nM, FLT3 IC50 = 30 nM), and it also showed potent inhibition against the above tested cell lines. In the cellular context, 14j strongly induced apoptosis by arresting cell cycle in the G(1)/S phase, and was selected as a promising JAK2/FLT3 dual inhibitor. (C) 2019 Elsevier Masson SAS. All rights reserved.
Welcome to talk about 88-68-6, If you have any questions, you can contact Li, YX; Ye, TY; Xu, L; Dong, YH; Luo, Y; Wang, C; Han, YF; Chen, K; Qin, MZ; Liu, YJ; Zhao, YF or send Email.. Name: 2-Aminobenzamide
Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem